Steady as a rock
Sartorius Stedim Biotech has launched its new BIOSTAT® RM TX with Flexsafe® RM TX technology - a rocking-motion, single-use bioreactor system - to optimize the manufacture of cellular products maintaining consistent quality.30 Jan 2019
Sartorius Stedim Biotech (SSB), a leading global supplier to the biopharmaceutical industry, recently launched the innovative BIOSTAT® RM TX. This single-use bioreactor system has been specially developed for closed, automated expansion of cell products in a consistent quality, which would make it ideal for applications such as ex vivo cellular immunotherapies. According to SSB, this new ‘good manufacturing practice’ (GMP) platform perfectly blends its trusted Flexsafe® bag technology with its biopharmaceutical automation know-how.
"Combining single-use technology with advanced automation for the expansion of cell products ensures process variability can be controlled and turns safe, robust and affordable cell production into a reality," explains Dr. Franziska Faulstich, Global Product Manager for Regenerative Medicine and RM Bioreactors at Sartorius Stedim Biotech. Pointing out the great benefits this new single-use bioreactor offers to users, she adds: "We collaborated closely with leading cellular immunotherapy companies to identify the right technologies and best-practice workflows before incorporating them into our new BIOSTAT® RM TX bioreactor."
Sartorius Lab Instruments GmbH & Co. KG (37079 Göttingen, Germany)
Interested in news about exhibitors, top offers and trends in the industry?
Your web browser is outdated. Update your browser for more security, speed and optimal presentation of this page.Update Browser